Archived News
2022 Archived News
- International Collaboration to Improve Cancer Care in Sub-Saharan Africa Focuses on Resources for Children’s Cancers (12-15-2022)
- Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors (12-12-2022)
- Improving Cancer Outcomes for LGBTQ+ Patients Requires Earning Trust and Challenging Assumptions (12-02-2022)
- SLACOM and NCCN Launch International Project to Improve Breast Cancer Care in Argentina (11-16-2022)
- NCCN Announces Funding for Bladder Cancer Research Projects, in Collaboration with Pfizer and EMD Serono (11-10-2022)
- New Study in JNCCN Presents Evidence for ‘Tough Conversations’ Around Racism in Access to Cancer Care (11-09-2022)
- NCCN Working with Medlive to Advance High-Quality Cancer Care in China and Worldwide (11-02-2022)
- NCCN Guidelines for Patients Win Award for Excellence in Cancer Patient Education from CPEN (10-19-2022)
- Cancer Patients Treated with Immunotherapy Can Safely Receive mRNA COVID-19 Vaccines, According to JNCCN Study (10-17-2022)
- Irish Oncology Care Platform Announces Collaboration with NCCN (10-17-2022)
- On World Mental Health Day, NCCN Announces Free Updated Distress Screening Tool, Available in More Than 70 Languages (10-10-2022)
- NCCN Annual Congress on Hematologic Malignancies™ Returns to In-Person October 14–15, 2022 in New York City (09-27-2022)
- NCCN Updates Recommendations for COVID-19 Vaccination with Information on Bivalent Vaccines, Children with Cancer, and Other Developments (09-22-2022)
- Cancer Screening Gaps Highlight Urgent Need to Address Health Inequities, According to NCCN Policy Summit (09-16-2022)
- NCCN’s New Patient Guidelines for Marginal Zone Lymphoma Help Patients and Caregivers Better Understand a Rare Form of Blood Cancer (09-12-2022)
- New Study in JNCCN Suggests Way to Predict Outcomes with High Accuracy Prior to Surgery for Pancreatic Cancer Patients (09-08-2022)
- NCCN Announces Collaboration with Myovant Sciences and Pfizer to Support Projects to Understand and Mitigate Cardiovascular Risk in Patients with Prostate Cancer (08-30-2022)
- There’s a Better Way to Detect High-Risk Medications in Older Adults with Cancer According to New Study in JNCCN (08-10-2022)
- Chemotherapy Drugs from “Rogue” Online Pharmacies Could Endanger Leukemia Patients, Suggests Research in JNCCN (07-28-2022)
- NCCN Publishes New Patient Guidelines for Breast Cancer Screening and Diagnosis Emphasizing Annual Mammograms for All Average-Risk Women Over 40 (07-27-2022)
- National Comprehensive Cancer Network Shares New Recommendations for Treating Children with Brain Tumors (07-12-2022)
- JNCCN: Mismatch in Breast Cancer Trial Results and Real-World Outcomes Based on Treatment Discontinuation (06-21-2022)
- NCCN Policy Summit Speakers Say Flexibility in Supporting and Accommodating Cancer Patients and Caregivers Helps Workplaces Thrive (06-17-2022)
- National Comprehensive Cancer Network Honors Oncology Leaders Promoting Progress in Cancer Care (05-23-2022)
- UICC Announces a New Global Coalition to Increase Access to and the Use of Essential Cancer Medicines in Low- and Lower Middle-Income Countries (05-20-2022)
- New Research in JNCCN Encourages Harnessing Health Technology to Help Cancer Patients Quit Smoking (05-11-2022)
- BostonGene Announces Integration With NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) (05-10-2022)
- Updated Guidance for COVID-19 Vaccination from NCCN Recommends Fifth mRNA Shot (Second Booster Dose) for Immunocompromised People (04-27-2022)
- NCCN Foundation Announces Awards for Rising Cancer Research Leaders (04-25-2022)
- New Cancer Information Resources for People of Ukraine from NCCN (04-14-2022)
- Concerning Decline in Annual Screening for Breast Cancer Survivors Identified in JNCCN (04-07-2022)
- UT Southwestern’s Dr. John Sweetenham Elected Board Chair for National Comprehensive Cancer Network (04-05-2022)
- NCCN Announces Indiana University Melvin and Bren Simon Comprehensive Cancer Center as 32nd Member Institution (04-04-2022)
- NCCN Annual Conference Focuses on Cancer Patient Journey; with Cutting-Edge Research and Latest Evidence-Based Care Recommendations (03-31-2022)
- Free Guide to Colorectal Cancer Screening from NCCN Now Available in More Than a Dozen Languages (03-28-2022)
- NCCN Pharmacy Directors Forum Publishes Recommendations for Safely Dispensing Investigational Medications for Clinical Trials (03-15-2022)
- New Research in JNCCN Measures Drop in Cancer Detection Due to the COVID-19 Pandemic (03-14-2022)
- NCCN Expands Resources for Treating Rare Cancer Types (03-09-2022)
- Nearly 100 Cancer Organizations Urge Congress to Fund Cancer Moonshot Initiatives (02-28-2022)
- Reducing Hereditary Cancer Act Promises to Expand Access to Cancer Screenings and Interventions for High-Risk Medicare Beneficiaries (02-17-2022)
- mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN (02-07-2022)
- NCCN Joins the Call to ‘Close the Care Gap’ on World Cancer Day (02-04-2022)
- NCCN Announces Funding for Lung and Thyroid Cancer Quality Projects, in Collaboration with Lilly (01-24-2022)
- New Research in JNCCN Raises Awareness of the Dangers of Septic Shock in Blood Cancer Patients (01-12-2022)
- New Resource from NCCN Shares Evidence-Based Approaches to Recognize and Manage Graft-Versus-Host Disease after Stem Cell Transplantation (01-10-2022)
- Protecting People with Cancer from COVID-19: New Recommendations from Cancer Guidelines Organization (01-04-2022)